Effects and clinical implications of sacubitril/valsartan on left ventricular reverse remodeling in patients affected by chronic heart failure: A 24-month follow-up

BACKGROUND: Compared to angiotensin inhibition, angiotensin-neprilysin “blockade” improves mortality and reduces hospitalizations in patients with heart failure (HF) with reduced ejection fraction (EF). Sacubitril/valsartan is known to influence left ventricular (LV) reverse remodeling with systolic...

Descripción completa

Detalles Bibliográficos
Autores principales: Paolini, Carla, Mugnai, Giacomo, Dalla Valle, Chiara, Volpiana, Andrea, Ferraglia, Alessandra, Frigo, Anna Chiara, Bilato, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213880/
https://www.ncbi.nlm.nih.gov/pubmed/34179333
http://dx.doi.org/10.1016/j.ijcha.2021.100821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213880/
https://www.ncbi.nlm.nih.gov/pubmed/34179333
http://dx.doi.org/10.1016/j.ijcha.2021.100821

Ejemplares similares